The Efficacy of MDI Treatment With an Optimization Algorithm Adjusting Basal-Bolus Parameters in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp
Diabete Mellitus, Diabetes Mellitus, Type 1
About this trial
This is an interventional treatment trial for Diabete Mellitus focused on measuring Multiple Daily Injections, type 1 diabetes, pediatrics, optimization algorithm
Eligibility Criteria
Inclusion Criteria:
- Males and females between 8 and 18 years old.
- Clinical diagnosis of type 1 diabetes for at least 12 months. The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not needed.
- Undergoing multiple daily injection therapy.
- HbA1c ≤ 11%.
Exclusion Criteria:
- Serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
- Failure to comply with the study protocol or with team's recommendations.
- Injection of isophane insulin (NPH) or any intermediate-acting insulin
- More than one injection of slow-acting insulin per day.
Sites / Locations
- Camp Carowanis
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
MDI with Physician Adjusted Basal-Bolus Parameters
MDI with Basal-Bolus Optimization Algorithm
Participants will be wearing the Freestyle Libre glucose sensor (Abbott Diabetes Care). Participants will undergo their conventional multiple daily injection (MDI) therapy.
Participants will be wearing the Freestyle Libre glucose sensor (Abbott Diabetes Care). Once daily, the data from the glucose sensor and injection information will be entered into a computer and the optimization algorithm will be run. Once daily, participants' parameters may be changed based on the algorithm's recommendations.